310 related articles for article (PubMed ID: 19954059)
1. [The effect of valsartan and fluvastatin on the connective tissue growth factor expression in experimental diabetic cardiomyopathy].
Wang YJ; Fu GS; Chen FM; Wang H
Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):660-5. PubMed ID: 19954059
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
[TBL] [Abstract][Full Text] [Related]
3. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
4. [The expression of connective tissue growth factor in renal cortex of 5/6 nephrectomized rats and its modulation by fluvastatin].
Song GW; Li C; Zheng YC; Kong J; Sun B
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1428-32. PubMed ID: 14521748
[TBL] [Abstract][Full Text] [Related]
5. [The therapeutic effects of bosentan and valsartan on renal interstitial fibrosis of chronic aristolochic acid nephropathy].
Zhang C; Chen YP; Dong HR; Qiu CB
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2601-6. PubMed ID: 16321319
[TBL] [Abstract][Full Text] [Related]
6. Fluvastatin-induced reduction of oxidative stress ameliorates diabetic cardiomyopathy in association with improving coronary microvasculature.
Shida T; Nozawa T; Sobajima M; Ihori H; Matsuki A; Inoue H
Heart Vessels; 2014 Jul; 29(4):532-41. PubMed ID: 23979266
[TBL] [Abstract][Full Text] [Related]
7. Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1-connective tissue growth factor signalling cascade.
Huang J; Matavelli LC; Siragy HM
Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):215-21. PubMed ID: 21265872
[TBL] [Abstract][Full Text] [Related]
8. The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts.
Shin YH; Min JJ; Lee JH; Kim EH; Kim GE; Kim MH; Lee JJ; Ahn HJ
Heart Vessels; 2017 May; 32(5):618-627. PubMed ID: 28013371
[TBL] [Abstract][Full Text] [Related]
9. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
[TBL] [Abstract][Full Text] [Related]
10. [Protection and mechanism of shenqi compound for diabetic angiopathy model rats].
Hu YH; Hou J; Zheng DZ; Li DD; Hao XZ; Xie CG; Du L; Ni Q; Shen Y; Li J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Sep; 34(9):1078-85. PubMed ID: 25335332
[TBL] [Abstract][Full Text] [Related]
11. The impact of 1,25-dihydroxyvitamin D3 on the expression of connective tissue growth factor and transforming growth factor-β1 in the myocardium of rats with diabetes.
Wang L; Yuan T; Du G; Zhao Q; Ma L; Zhu J
Diabetes Res Clin Pract; 2014 May; 104(2):226-33. PubMed ID: 24613393
[TBL] [Abstract][Full Text] [Related]
12. [Renal protective effect of valsartan in diabetic rats].
Wen H; Lin S
Zhonghua Nei Ke Za Zhi; 1999 Mar; 38(3):157-60. PubMed ID: 11798641
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.
Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH
Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320
[TBL] [Abstract][Full Text] [Related]
14. [Berberine inhibits cardiac fibrosis of diabetic rats].
Lu K; Shen Y; He J; Liu G; Song W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1352-1355. PubMed ID: 27667461
[TBL] [Abstract][Full Text] [Related]
15. [Effect of valsartan on Tribble 3 gene expression in rats with experimental diabetic cardiomyopathy].
Zhang W; Zhong M; Tang MX; Ma X; Miao Y; Sun H; Zhang Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Mar; 34(3):212-6. PubMed ID: 16630451
[TBL] [Abstract][Full Text] [Related]
16. Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation.
Horiuchi M; Cui TX; Li Z; Li JM; Nakagami H; Iwai M
Circulation; 2003 Jan; 107(1):106-12. PubMed ID: 12515751
[TBL] [Abstract][Full Text] [Related]
17. Expression of serum and glucocorticoid-inducible kinase1 in diabetic rats and its modulation by fluvastatin.
Wang X; Luo C; Liu J; Zhang C; Wang Y; Zhu Z
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):651-4. PubMed ID: 16696316
[TBL] [Abstract][Full Text] [Related]
18. [Triptolide combined with irbesartan synergistically blocks podocyte injury in a type 2 diabetes rat model].
Ma RX; Xu Y; Zhang J; Li YS; Liu LQ
Zhonghua Nei Ke Za Zhi; 2012 Feb; 51(2):117-22. PubMed ID: 22490812
[TBL] [Abstract][Full Text] [Related]
19. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
[TBL] [Abstract][Full Text] [Related]
20. Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus.
Yang ZH; Peng XD
Chin Med J (Engl); 2010 Dec; 123(24):3640-3. PubMed ID: 22166644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
